Byung-soo N. Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Engineered extracellular vesicles reprogram T cells by targeting PD-1 and PHB1 signaling in inflammatory bowel disease.

Engineered extracellular vesicles reprogram T cells by targeting PD-1 and PHB1 signaling in inflammatory bowel disease.

Journal: Signal transduction and targeted therapy

Published: July 30, 2025

Advances in mRNA-Lipid Nanoparticle Engineering for Immune Cell Targeting and Immune Modulation.

Advances in mRNA-Lipid Nanoparticle Engineering for Immune Cell Targeting and Immune Modulation.

Journal: Small methods

Published: July 16, 2025

Engineered Nanoparticles for Enhanced Antitumoral Synergy Between Macrophages and T Cells in the Tumor Microenvironment.

Engineered Nanoparticles for Enhanced Antitumoral Synergy Between Macrophages and T Cells in the Tumor Microenvironment.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: July 17, 2024

Strategies to Overcome Hurdles in Cancer Immunotherapy.

Strategies to Overcome Hurdles in Cancer Immunotherapy.

Journal: Biomaterials research

Published: April 26, 2024

Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy.

Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy.

Journal: Nature communications

Published: February 15, 2024

Publisher Correction: Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model.

Publisher Correction: Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model.

Journal: Nature nanotechnology

Published: November 18, 2023

A Personalized Cancer Nanovaccine that Enhances T-Cell Responses and Efficacy Through Dual Interactions with Dendritic Cells and T Cells.

A Personalized Cancer Nanovaccine that Enhances T-Cell Responses and Efficacy Through Dual Interactions with Dendritic Cells and T Cells.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: April 28, 2023

Tolerogenic nanoparticles induce type II collagen-specific regulatory T cells and ameliorate osteoarthritis.

Tolerogenic nanoparticles induce type II collagen-specific regulatory T cells and ameliorate osteoarthritis.

Journal: Science advances

Published: November 25, 2022

Immunomodulation for Tissue Repair and Regeneration.

Immunomodulation for Tissue Repair and Regeneration.

Journal: Tissue engineering and regenerative medicine

Published: October 20, 2022

Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model.

Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model.

Journal: Nature nanotechnology

Published: September 17, 2022

Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine.

Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine.

Journal: Experimental & molecular medicine

Published: August 01, 2022

A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis.

A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis.

Journal: ACS biomaterials science & engineering

Published: April 13, 2022

Showing 1-12 of 114

Last Updated: 09/26/2026